Transamniotic stem cell therapy (TRASCET) in a leporine model of gastroschisis

Transamniotic stem cell therapy (TRASCET) with amniotic fluid mesenchymal stem cells (afMSCs) has been shown to mitigate bowel damage in a rodent model of gastroschisis. As a prerequisite to clinical translation, we sought to study TRASCET in a larger animal model.

Source: Journal of Pediatric Surgery - November 7, 2016 Category: Surgery Authors: Christina Feng, Christopher D Graham, Hester F. Shieh, Joseph A Brazzo, John Patrick Connors, Lucas Rohrer, Alexander Papadakis, David Zurakowski, Dario O Fauza Source Type: research